300015 Stock Overview
Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 300015 from our risk checks.
Aier Eye Hospital Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥12.08 |
52 Week High | CN¥23.27 |
52 Week Low | CN¥11.80 |
Beta | 0.46 |
1 Month Change | -7.29% |
3 Month Change | -13.41% |
1 Year Change | -45.68% |
3 Year Change | -64.89% |
5 Year Change | 19.76% |
Change since IPO | 196.63% |
Recent News & Updates
Recent updates
Shareholder Returns
300015 | CN Healthcare | CN Market | |
---|---|---|---|
7D | -3.4% | 1.9% | 1.6% |
1Y | -45.7% | -32.4% | -15.1% |
Return vs Industry: 300015 underperformed the CN Healthcare industry which returned -32.4% over the past year.
Return vs Market: 300015 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
300015 volatility | |
---|---|
300015 Average Weekly Movement | 5.0% |
Healthcare Industry Average Movement | 6.8% |
Market Average Movement | 8.8% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 300015 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300015's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 32,326 | Li Li | www.aierchina.com |
Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract.
Aier Eye Hospital Group Co., Ltd. Fundamentals Summary
300015 fundamental statistics | |
---|---|
Market cap | CN¥112.69b |
Earnings (TTM) | CN¥3.35b |
Revenue (TTM) | CN¥19.11b |
33.3x
P/E Ratio5.8x
P/S RatioIs 300015 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300015 income statement (TTM) | |
---|---|
Revenue | CN¥19.11b |
Cost of Revenue | CN¥9.42b |
Gross Profit | CN¥9.69b |
Other Expenses | CN¥6.34b |
Earnings | CN¥3.35b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | 0.36 |
Gross Margin | 50.71% |
Net Profit Margin | 17.53% |
Debt/Equity Ratio | 5.6% |
How did 300015 perform over the long term?
See historical performance and comparison